View the CYPRESS registration information details.
Back to drug list
ItemsDrug Registration information
ID463
No463
Brand NameCYPRESS
IngredientsCYPROTERONE ACETATE PH.EUR 2 MG, ETHINYLESTRADIOL PH.EUR 0.035 MG
Dosage FormFILM COATED TABLET
Primary PackagingALU/PVDC
Storage
Shelf Life2 YEARS
Pack SizeA BLISTERPACK OF 21 TABLETS
Dispensing Category
ATC Classification
Pharmaceutical Class
IndicationsTREATMENT OF MODERATE TO SEVERE ACNE RELATED TO ANDROGEN-SENSITIVITY (WITH OR WITHOUT SEBORRHOEA) AND/OR HIRSUTISM, IN WOMEN OF REPRODUCTIVE AGE. FOR THE TREATMENT OF ACNE, CYPRESS SHOULD ONLY BE USED AFTER THERAPY OR SYSTEMIC ANTIBIOTIC TREATMENTS HAVE FAILED
Contraindications
Side Effects
Unit Price
EDLNULL
DescriptionROUND, LIGHT PINK, BICONVEX, FILM COATED TABLET DEBOSED " T" ON ONE SIDE AND OTHER SIDE PLAIN
Note
License OwnerDKSH LAOS COMPANY LIMITED
ManufacturerMYLAN LABORATORIES LIMITED
CountryINDIA
Import Registration No
Import Registration Date
ActivityCERTIFICATE RELEASED
Applied Date
FDD Registration No01 I 5665/24
FDD Registration Date26/01/2024
Expiry Date25/01/2027
Back to drug list
ADB ASEAN COVID-19 Laos JICA KOICA Global Fund WFP UHS Laos World Bank MOH Laos UNODC WHO SIDA